BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 3067-3072

  Barnes, M G ^a   Weiss, A A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT COMPONENT C1; PROTEIN BRKA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BORDETELLA PERTUSSIS; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; GENE INSERTION; GENE LOCUS; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

BACTERIAL OUTER MEMBRANE PROTEINS; COMPLEMENT C1; COMPLEMENT C1Q; COMPLEMENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, CLASSICAL; HEAT; HUMANS;

EID: 0035060657     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.3067-3072.2001     Document Type: Article

References (33)

1. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function
2. Bordetella pertussis binds the human complement regulator C4BP: Role of filamentous hemagglutinin
3. Human C1 inhibitor: Primary structure, cDNA cloning, and chromosomal localization
4. Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain
5. Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5
6. Complement evasion strategies of microorganisms
7. Cloning and sequencing of a Bordetella pertussis serum resistance locus
8. Serum resistance in bvg-regulated mutants of Bordetella pertussis
9. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass
10. The mechanism by which microorganisms avoid complement attack
11. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein
12. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3
13. Fluorometric detection of low temperature thermal transitions in the C1Q component of human complement
14. Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H
15. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
16. Complement evasion by bacteria and parasites
17. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex
18. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
19. Complement resistance in microbes
20. Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae
21. Plasma exudation in the airways: Mechanisms and function
22. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3
23. Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59)
24. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation
25. Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation
26. Mutations in the bvgA gene of Bordetella pertussis that differentially affect regulation of virulence determinants
27. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
28. BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli
29. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils
30. Mucosal immune defenses and the response of Bordetella pertussis
31. Tn5-induced mutations affecting virulence factors of Bordetella pertussis
32. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes
33. Characterization of human bactericidal antibodies to Bordetella pertussis